As of Oct 27
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 24.00, with a high estimate of 33.00 and a low estimate of 15.00. The median estimate represents a +318.85% increase from the last price of 5.73.
The current consensus among 7 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.